دورية أكاديمية

Seven years' follow-up of comparative study between stenting and medication for treatment of symptomatic vertebrobasilar artery stenosis.

التفاصيل البيبلوغرافية
العنوان: Seven years' follow-up of comparative study between stenting and medication for treatment of symptomatic vertebrobasilar artery stenosis.
المؤلفون: Jun Wang, Changyang Zhong, Yan Zhang, Yingnan Wei, Huili Liu, Chunli Wu, Yongxing Yan
المصدر: Interventional Neuroradiology; Feb2018, Vol. 24 Issue 1, p43-50, 8p
مصطلحات موضوعية: ARTERIAL stenosis treatment, ANGIOPLASTY, SURGICAL stents, BLOOD flow, CEREBRAL ischemia
مستخلص: Objective: Endovascular stent-assistant angioplasty (ESAA) is a valid treatment for symptomatic vertebrobasilar artery stenosis (SVAS), but the long-term effect and the improvement of condition compared with medication treatment are unknown. This study investigated the long-term efficacy of ESAA in patients with moderate and severe SVAS, and compared the efficacy with medication treatment. Materials and methods: We conducted a retrospective analysis of clinical data of 43 patients with moderate and severe SVAS hospitalized in our department. According to different treatment methods they were divided into 29 cases in an ESAA group and 14 cases in a medication treatment group. During the follow-up period, the degree of vascular stenosis, vascular blood flow velocity, restenosis rate, recovery of neurological function and the incidence of cerebral ischemic events in the two groups were analyzed. Results: The average clinical follow-up period was 89.4±10.2 months. Before treatment, the stenosis rate and average blood flow velocity of the two groups were not statistically significant (p>0.05). During the follow-up period, both were significantly lower than the medication treatment group (p<0.01). In the ESAA group, three cases of stent stenosis, and three cases in the medication treatment group were completely occluded. The total ischemic events in ESAA group were three cases, compared with nine cases in the medication treatment group; the difference was statistically significant (p<0.05). Conclusion: ESAA has a long-term effect in the treatment of symptomatic moderate and severe vertebrobasilar artery stenosis. It is superior to medication therapy in preventing posterior circulation ischemia (PCI), but a larger sample size is still needed to confirm the study. [ABSTRACT FROM AUTHOR]
Copyright of Interventional Neuroradiology is the property of Sage Publications, Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:15910199
DOI:10.1177/1591019917736032